Photo: The Week
WHO Team Likely To Approve Covaxin's Emergency Use In Next Meet
Chief Scientist at the World Health Organisation Soumya Swaminathan on October 17 said that the technical advisory group of the WHO will consider the Emergency use listing for Covaxin during the meeting on October 26. If the approval is granted, it'll expand the list of vaccines approved by the WHO to send it to poor countries. Reportedly, Covaxin's manufacturer Bharat Biotech is also hopeful to get the approval.
Tags: Covaxin, WHO, Emergency Use Listing, Bharat biotech
Courtesy: WION
Covaxin
India's Homegrown Covaxin To Get WHO Approval Soon
WHO is likely to take a call on emergency use listing of India's homegrown 'Covaxin' developed by Bharat Biotech in four to six weeks, Chief WHO Scientist Dr. Soumy Swaminathan said. The safety data, complete trial data, and manufacturing quality data for approval have been submitted by Bharat Biotech for review. Covaxin is now accepted in 16 countries and has shown 77.8% efficiency against symptomatic infection, as per reports.
Tags: Covid-19, Covaxin, Emergency Use Listing, WHO, WHO Chief
Courtesy: Hindustan Times
